IV ketamine staves off suicide in the short term: study
New placebo-controlled trial shows two infusions a day apart leads to full remission in more patients at day three
2 minutes to read
22nd February 2022
More patients with severe suicidal ideation achieve full remission in the short term with intravenous ketamine than those not treated with the drug, reports a new placebo-controlled trial
However, the French researchers caution that the potential for abuse and lack of longer-term benefit may limit the drug's
